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E-mail address: winfried.hinrichs@uni-greifswald.dThe ﬂavin-dependent monooxygenase TetX confers resistance to all clinically relevant tetracyclines,
including the recently approved, broad-spectrum antibiotic tigecycline (Tygacil) which is a critical
last-ditch defense against multidrug-resistant pathogens. TetX represents the ﬁrst resistance mech-
anism against tigecycline, which circumvents both the tet-gene encoded resistances, relying on
active efﬂux of tetracyclines, and ribosomal protection proteins. The alternative enzyme-based
mechanism of TetX depends on regioselective hydroxylation of tetracycline antibiotics to 11a-
hydroxy-tetracyclines. Here, we report the X-ray crystallographic structure determinations at
2.1 Å resolution of native TetX from Bacteroides thetaiotaomicron and its complexes with tetracy-
clines. Our crystal structures explain the extremely versatile substrate diversity of the enzyme
and provide a ﬁrst step towards the rational design of novel tetracycline derivatives to counter
TetX-based resistance prior to emerging clinical observations.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
One of the most powerful compounds to treat complicated skin
and skin-structure infections (cSSSIs) and intra-abdominal infec-
tions (cIAIs) is tigecycline (Tygacil, Wyeth Pharmaceuticals), a re-
cently-approved, 3rd generation tetracycline (Tc). Tigecycline is a
glycylcycline with a 9-tert-butylglycylamido group [1]. Functional
assays demonstrate that tigecycline inhibits ribosomal protein
synthesis with 3-fold higher efﬁcacy than the second generation
tetracycline minocycline and 20-fold more than the parent com-
pound Tc [2]. Tigecycline was introduced into clinical practice in
2005–2006 and has been of great value as a last line of defense
against multi-drug resistant bacteria, including the recently identi-
ﬁed Gram negative pathogens bearing the NDM-1 carbapenemase
[3]. Importantly, tigecycline is also active in vitro against Tc-resis-
tant bacteria harboring genes responsible for ribosomal protection
and drug efﬂux, including methicillin-resistant Staphylococcus aur-
eus (MRSA), vancomycin-resistant enterococci (VRE), multi-drug
resistant Acinetobacter sp., and extended spectrum beta-lactamase
(ESBL)-producing Gram-negative organisms [1]. To date, tigecy-
cline resistance in hospital-associated pathogens has been rare.
However, an efﬂux-based resistance mechanism leading to re-chemical Societies. Published by E
e (W. Hinrichs).duced susceptibility for tigecycline was reported recently for Acine-
tobacter [4].
A completely new tigecycline resistance mechanism is con-
ferred by the ﬂavin-dependent monooxygenase TetX. This enzyme
catalyzes regioselective hydroxylation of tetracyclines to 11a-hy-
droxy-tetracyclines (Fig. 1). The hydroxylated tetracyclines de-
grade non-enzymatically to as yet uncharacterized products [5].
TetX is able to accept tigecycline as substrate in this NADPH and
molecular oxygen dependent hydroxylation [6], which makes aer-
obic strains harboring tetX highly resistant against tigecycline.
Hydroxylated tetracyclines have signiﬁcantly reduced antibiotic
properties as a result of their fast degradation [6] combined with
a weaker coordination of Mg2+-ions, which is crucial for their bind-
ing to the ribosome [7,8]. To date, Tc resistance by TetX is not dom-
inant in clinical settings and therefore this is the ﬁrst time that
structural details of resistance are available before the clinical
observation of resistance.
Paradoxically, tetX was found on transposons Tn4351 and
Tn4400 [9,10] in the anaerobe Bacteroides fragilis during cloning
and expression of a clindamycin–erythromycin resistance gene.
TetX expression in B. fragilis cannot confer Tc resistance because
of the requirement of molecular oxygen for enzyme activity [11].
The orthologous genes tetX1 and tetX2 were identiﬁed on CTnDOT
in Bacteroides thetaiotaomicron. The amino acid sequence deduced
for TetX shares 61.7% and 99.5% sequence identity, respectively,
with TetX1 and TetX2. The tetX gene was found in aerobic Sphingo-
bacterium sp. strain PM2-P1-29 with 99.8% nucleotide and 100%lsevier B.V. All rights reserved.
Fig. 1. (A) Structure and nomenclature of 7-chlortetracycline and TetX-mediated reaction to 11a-hydroxy-7-chlortetracycline. (B) Structure of 7-iodtetracycline. (C) Structure
of tigecycline which carries a 9-tert-butylglycylamido group at the D-ring.
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Sphingobacterium harboring tetX is resistant to tetracyclines [12].
Because of the low GC content of tetX (39%) it is more likely that
Sphingobacterium sp. (37%) or other, related, soil bacteria are the
ancestral source of the tetX-genes, not Bacteroides (43%) [12]; this
would not be uncommon, given the diversity of the antibiotic resis-
tome and multi-drug resistance in soil bacteria [13]. Therefore it is
uncertain whether TetX solely maintains antibiotic resistance or
whether it has other unknown functions like biosynthesis or catab-
olism in ancestral soil bacteria.
2. Methods
The crystal structure of TetX from B. thetaiotaomicron was
solved by multiple-wavelength anomalous-dispersion using a sele-
nomethionine-labeled protein crystallized in the monoclinic space
group P21 with four molecules in the asymmetric unit [14–17]. The
TetX structure was then reﬁned against X-ray diffraction data from
a native TetX crystal in space group P1 to a resolution of 2.1 Å.
These crystals were soaked with different tetracyclines to study
substrate recognition. We collected diffraction data of TetX com-
plexes with 7-ITc and 7-ClTc at 2.4 and 3.1 Å resolution, respec-
tively. In all structures the coenzyme ﬂavin adenine dinucleotide
(FAD) was clearly recognized in the electron density for each TetX
monomer (Fig. S5B). Electron density of tetracycline molecules was
clearly identiﬁed in the substrate binding pocket close to the FAD
and included in reﬁnement of the structural models. Crystallo-
graphic details are reported and summarized in supporting online
material, Tables S1 and S2 [15].
3. Results
3.1. Overall structure of TetX
The crystal structure of TetX from B. thetaiotaomicron was
solved by multiple-wavelength anomalous-dispersion using a sele-
nomethionine-labelled protein crystallized in the monoclinic space
group P21 [14,15]. The TetX structure was then reﬁned against X-ray diffraction data from a native TetX crystal in space group P1
to a resolution of 2.1 Å. These crystals were soaked with different
tetracyclines to study substrate recognition. We collected diffrac-
tion data of TetX complexes with 7-iodtetracycline (7-ITc) and 7-
chlortetracycline (7-ClTc) at 2.4 and 3.1 Å resolution, respectively.
The asymmetric unit of both crystal forms consists of four TetX
monomers arranged as pairs of dimers. A search with PISA [18]
does not suggest any larger assemblies between monomers nor
interfaces that are not crystal contacts. Therefore, it is unlikely that
TetX forms quaternary structures in solution; indeed, the enzyme
is known to be a monomer in solution [5].
In all structures the coenzyme ﬂavin adenine dinucleotide
(FAD) was clearly recognized in the electron density for each TetX
monomer (Fig. 3B). Electron density of tetracycline molecules were
clearly identiﬁed in the substrate binding pocket close to the FAD
and included in reﬁnement of the structural models.
The enzyme is composed of two domains where the polypep-
tide chain (383 amino acid residues) alternates four times between
the domains (Fig. 2). Domain 1 exhibits the Rossmann fold [19]
responsible for binding of the coenzyme FAD through its adenosine
monophosphate component, which is linked to the ﬂavin mononu-
cleotide containing the catalytically active isoalloxazine moiety.
The second domain with an extended 7-stranded b-sheet is posi-
tioned like a shield on top of the ﬂavin-binding domain covered
by ﬁve a-helices and is responsible for substrate recognition. A
long C-terminal a-helix (10 turns) stabilizes the association of
the two domains.
Sequence comparisons and a search with DALI [20] in the Pro-
tein Data Bank using the TetX coordinates reveal that TetX belongs
to the family of FAD-dependent aromatic hydroxylases which takes
its name from p-hydroxybenzoate hydroxylase (pHBH) of Pseudo-
monas aeruginosa [21] (Fig. S3).
The monooxygenase reaction mechanism relies on the redox
properties of FAD. After reduction to FADH2 by NADPH the isoal-
loxazine binds molecular oxygen at C4a forming a hydroperoxide,
which hydroxylates the substrate [22]. The critical point is the
FAD-OOH intermediate, which has to be protected against hydroly-
sis to prevent the alternative oxidase reaction generating H2O2.
Fig. 2. Ribbon plot of TetX monooxygenase indicating the subdivision into domains
by coloring. FAD (stick model) adopts the IN conformation. The si side of the ﬂavin is
facing the viewer.
Fig. 3. The FAD binding site of TetX. (A) FAD is shown in orange, protein carbon atoms in
are highlighted in purple. Hydrogen-bonding interactions are shown as dashed lines. (B
structure factor calculation (2Fo-Fc, blue, 1.5 r; Fo-Fc, green, 3.0 r).
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fold the FAD hydroperoxide is formed after substrate recognition,
shielding the hydroperoxide from solvent; subsequently, direct
substrate hydroxylation takes place.
3.2. The FAD binding site of TetX
The FAD binding site is well conserved. Characteristically, the
turn connecting b1 and a1 is composed of a consensus binding mo-
tif GXGXXG responsible for FAD-binding [23]. In TetX, this motif is
represented by residues GGGPVGwhere glycine in position two oc-
curs frequently [24]. FAD is bound non-covalently in an elongated,
so-called IN conformation (see below) with the adenine and isoal-
loxazine moieties distal to each other (Figs. 2 and 3). The dimeth-
ylbenzene ring of the ﬂavin is oriented between the methylene
chain of P318 on the re side and G57/58 on the si side. A similar
stacking was found for several members of the pHBH family, e.g.
polyketide oxygenase PgaE from Streptomycetes (PDB accession,
2QA1, 16.2% sequence identity) [25]. The 20 and 30 hydroxyl groups
of the ribose are bound by the carboxylate of the conserved E46
through strong hydrogen bonds (2.65 Å).
In several pHBH-members the isoalloxazine moiety of FAD is
able to adopt alternatively the so called IN or the OUT conforma-
tion to regulate accessibility of the active site [26] and to maintain
ﬂavin-reduction by NADPH [27]. The IN conformation of FAD is be-
lieved to be necessary for reaction of ﬂavin with molecular oxygen
and subsequent hydroxylation of the aromatic substrate. When
bound in the OUT conformation, isoalloxazine is bent towards
the adenine. This is important to bring C4a of FAD and NADPH in
close contact for reduction [28]. In TetX the FAD is found in the
elongated IN conformation. The IN conformation is more often ob-
served for oxidized ﬂavin but also for reduced ﬂavin after reduction
by NADPH (PDB accession, 3EPT) [29]. In the TetX crystal structure
the FAD is bound in its oxidized state leading to yellow proteingreen and water as red spheres. The carbon atoms of the conserved GGGPVG motif
) Omit electron density map at 2.09 Å resolution where FAD was omitted from the
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results in colorless crystals as reported for RebC [29]. In the case of
pHBH from Pseudomonas ﬂuorescens the IN conformation of the ﬂa-
vin ring is adopted when substrate [30] or NADPH binds
(pHBHR220Q from P. aeruginosa, PDB accession, 1K0J) [28], leading
to a closed conformation of the active site. In contrast to RebC
and pHBH, the ﬂavin moiety of TetX adopts the IN conformation
with well-deﬁned electron density even in the absence of substrate
and NADPH. The IN conformation in the absence of substrate was
also found for DHPH, MHPCO and PgaE, which has a comparable
large substrate binding site. PgaE is involved in the biosynthesis
of angucycline, which shares a similar size with tetracyclines [31].
3.3. Tetracycline and oxygen recognition by TetX
Speciﬁc tetracycline binding was investigated by diffraction
data of tetracycline soaked TetX crystals. Suitable data sets re-
vealed speciﬁc contacts of 7-ITc and 7-ClTc to the isoalloxazine
of FAD in the large active site cavity. In both crystal structures
the tetracycline molecules are unambiguously identiﬁed in the
electron density maps and reﬁned in all TetX molecules of the
asymmetric unit. All Tc molecules adopt a very similar orientation
to the FAD cofactor, which adopts the IN conformation similar to
the native TetX.
Tetracycline binding in the active site is mediated by hydrogen-
bonding interactions of the A-ring with residues Q192, R213, H234
and the backbone carbonyl-oxygen of G236 of domain 2 (Fig. 4A).
Furthermore, the hydrophobic part of the Tc framework shows sev-
eral interactions with hydrophobic side chains (F224, M215, G321
and M375). The hydroxylation site C11a of Tc is at an appropriate
short distance (5.9 Å) to C4a of the isoalloxazine which forms theFig. 4. (A) Active site recognition of 7-ITc by hydrogen-bonding of TetX (protein
green, 7-ITc yellow, FAD orange, hydrogen bonds as black dashed lines in the range
of 2.7–3.2 Å). (B) Superposition of 7-ITc:TetX with the 7-ClTc:TetX complex (blue)
reveals a similar binding mode due to recognition of the conserved A-ring. The
hydroxylation target C11a of Tc is at an appropriate short distance (5.9 Å, dotted
line) to C4a of the FAD, which forms the hydroperoxide with molecular oxygen.hydroperoxide by oxygenation (Fig. 4B). The orientation of the sub-
strate to the cofactor is determined by hydrogen bonds of O4 and
N5 of FAD to the keto-enol moiety (O12) and the adjacent hydroxyl
group O12a of Tc. FAD reduction to FADH2 may strengthen these
hydrogen-bond interactions. This binding mode explains the sub-
strate diversity of TetX, tolerating all clinically relevant tetracy-
clines. All of them have a variable D-ring but a conserved A-ring
substitution pattern.
The bound Tc in the active site of TetX closes a strongly hydro-
phobic pocket near the ﬂavin re side in combination with mostly
aromatic residues of the 2nd domain in a water-free environment
(Fig. 5A and D). This pocket close to C4a of the ﬂavin is composed of
residues F319, L222, F224, M375, F376, F380 and F382. The pocket
was readily identiﬁed upon superposition with the Xenon deriva-
tive of 3-hydroxybenzoate hydroxylase mHBH from Comamonas
testosteroni (PDB accession, 2DKI) (Fig. 5B and Fig. S4). Xenon-bind-
ing studies on crystals of mHBH revealed the putative oxygen-
binding site necessary for the oxygenation of FADH2 and stabiliza-Fig. 5. (A) A putative oxygen binding site can be assigned to a strongly hydropho-
bic, solvent free pocket near to the active site of TetX with a clear separation to the
solvent region (FAD in orange, protein as a ribbon in green, hydrophobic side chains
in red, water as red dots). (B) Surface view of the hydrophobic pocket (hydrophobic
residues with red surface, hydrophilic blue). (C) The narrowest diameter of the
substrate entrance of TetX (shown as ribbons with side chains as sticks) is 8.6 Å
(black line). (D) Binding of 7-ITc (yellow) closes the hydrophobic pocket and
enables oxygen binding and transport (red line) along the hydrophobic site of 7-ITc
towards C4a of the FAD. (E) Omit electron density map where 7-ITc was omitted
from the structure factor calculation (2Fo-Fc, blue, 1.0 r; Fo-Fc, green, 3.0 r).
G. Volkers et al. / FEBS Letters 585 (2011) 1061–1066 1065tion of the FAD-OOH intermediate [32]; the hydrophobic pocket in
TetX may play a similar role.
4. Discussion
The antibiotic entrance and the NADPH binding site are rather
large, and we predict them to be at opposite ends of the active site
tunnel, in contrast to pHBH where substrate and NADPH enter
through one cavity pointing towards the re side, with a second
low-afﬁnity substrate-binding site [28]. The TetX structure reveals
a large, tunnel-like, substrate binding site connecting bulk solvent
and active site, which is shielded at one end by the C-terminal helix
a12 and strand b4. The narrowest diameter of the tunnel entrance
is 8.6 Å, between NH2 of R213 and CO of A320 (Fig. 5C). We pre-
sume the entrance for the antibiotic is here, in contrast to pHBH,
where active site access is provided through a cavity on the oppo-
site side. Thus, free access to the active site can be easily provided
without ﬂavin movement, even for large substrates. The substrate
entrance proposed for pHBH is blocked in the TetX crystal structure
by amino acid residues from strand b13.
Superposition of TetX with the pHBHR220Q:NADPH complex
(PDB accession, 1K0J; [28]) enables us to assign a putative NADPH
binding role to R54, similar to R44 from pHBH. R44 stabilizes the
20-phosphate group via a salt bridge and, together with the isoal-
loxazine of the FAD, it maintains the NADPH adenine in a sandwich
orientation. The guanidinium group of R54 of TetX has to be shifted
by about 12 Å to bring NADPH and FAD in close contact. This might
be possible, because R54 is located in a long loop connection with-
in the rigid Rossmann fold domain.
Overcoming the TetX resistance mechanism by drug design will
be challenging. Tigecycline is the most prominent member of the
glycylcyclines, which all have bulky hydrophobic substituents in
position 9 of the D-ring. This modiﬁcation results in increased
afﬁnity for the target ribosome and overcomes efﬂux and ribo-
somal protection resistance mechanisms, but not TetX-mediated
inactivation. Our crystal structures of TetX:Tc complexes show
clearly that the D-ring is solvent exposed. Furthermore, the hydro-
phobic part of the Tc makes few speciﬁc interactions with the en-
zyme. Unfortunately, only these regions of Tc can be varied if the
antibiotic function is to be retained. The portion of Tc that makes
the speciﬁc interactions with TetX has a substitution pattern that
is mandatory for antibiotic action (see above) and cannot be easily
redesigned. Ring A however may be an area worthy of modiﬁca-
tion. The carboxamide group on ring A interacts closely with both
TetX and TetR, the Tc-dependent repressor of the Tc efﬂux pump
[33]. However, this group interacts with the ribosome only through
a single hydrogen bond with the ribose of the nucleotide C1195 [7].
Fourth generation tetracycline antibiotics that incorporate modiﬁ-
cation of ring D at position 9 as well as modiﬁcation of the carbox-
amide group of ring A, which is now chemically possible through
new synthetic strategies [34], could overcome all known Tc resis-
tance mechanisms.
5. PDB accession numbers
The X-ray crystallographic coordinates and structure factors of
the native TetX, the SeMet-labeled TetX, and complexes of TetX
with 7-iodtetracycline and 7-chlortetracycline have been depos-
ited in the Protein Data Bank (PDB) with accession codes 2XDO,
2XYO, 2Y6Q, 2Y6R, respectively.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2011.03.012.References
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